Uterine Manipulators Market Report 2026

The uterine manipulators market size has grown strongly in recent years. It will grow from $0.41 billion in 2025 to $0.43 billion in 2026 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to increasing volume of gynecological surgeries, adoption of laparoscopic techniques, availability of reusable surgical instruments, expansion of hospital surgical infrastructure, rising focus on procedural efficiency.

The uterine manipulators market size is expected to see strong growth in the next few years. It will grow to $0.54 billion in 2030 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to increasing adoption of robotic-assisted gynecological surgeries, rising demand for advanced surgical tools, expansion of minimally invasive procedures, growing preference for disposable devices, increasing investment in surgical innovation. Major trends in the forecast period include increasing adoption of ergonomically designed manipulators, rising use of disposable and single-use devices, growing integration with minimally invasive surgical systems, expansion of robotic-assisted gynecological procedures, enhanced focus on surgical precision and safety.

The rising incidence of gynecological diseases is expected to drive the growth of the uterine manipulators market in the coming years. Gynecological diseases are medical conditions affecting the female reproductive system, including disorders of the uterus, ovaries, fallopian tubes, and cervix. Factors such as lifestyle changes, delayed pregnancies, increased stress, environmental pollutants, and a growing prevalence of obesity contribute to the rising incidence of these diseases. Uterine manipulators provide precise access and maneuverability during minimally invasive procedures, improving the diagnosis and treatment of gynecological conditions and enhancing patient outcomes. For example, in March 2023, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, reported that endometriosis affects approximately 190 million women and girls of reproductive age worldwide. Additionally, in February 2023, the American Cancer Society, a US-based nonprofit organization, projected that around 13,960 new cases of invasive cervical cancer would be diagnosed in 2023, with an estimated 4,310 women expected to die from the disease during the same period. Therefore, the increasing prevalence of gynecological diseases is driving growth in the uterine manipulators market.

Key companies in the uterine manipulators market are focusing on launching innovative products, such as advanced laparoscopic devices, to improve surgical precision, reduce patient recovery time, and enhance overall outcomes. Advanced laparoscopic devices are specialized surgical instruments used in minimally invasive procedures, allowing surgeons to operate through small incisions with improved visualization and accuracy. For instance, in January 2023, Lagis Enterprise Co. Ltd., a Taiwan-based medical device manufacturer, launched the Balloon Trocar, Uterine Manipulator-Injector at Arab Health. This device is designed to manipulate the uterus and inject fluids during gynecological procedures, enhancing visualization and control during minimally invasive surgeries. The balloon trocar creates a controlled entry point for laparoscopic procedures, with its balloon providing a secure seal and minimizing the risk of injury to surrounding tissues.

In November 2023, CooperCompanies Inc., a US-based medical device company, acquired select assets from Cook Medical for approximately $300 million. This acquisition aims to expand CooperSurgical’s medical device portfolio and strengthen its position in women’s health and surgical solutions. Cook Medical is a US-based company specializing in the provision of uterine manipulator injectors.

Major companies operating in the uterine manipulators market are Johnson & Johnson, Medtronic plc, Olympus Corporation, CooperSurgical Inc., Karl Storz SE & Co. KG, Conmed Corporation, Richard Wolf GmbH, MedGyn Products Inc., LSI Solutions Inc., LiNA Medical APS, Applied Medical Resources Corporation, Purple Surgical International Ltd, Conkin Surgical Instrument Ltd, Utah Medical Products Inc, Bistos Co Ltd, Minerva Surgical Inc, EndoMed Systems, Hangzhou Tonglu Shikonghou Medical Instrument Co Ltd, Gynex Corporation, Hospiline Equipments Pvt Ltd.

North America was the largest region in the uterine manipulators market in 2025. The regions covered in the uterine manipulators market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the uterine manipulators market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the uterine manipulators market by increasing costs of imported surgical instruments, precision components, medical-grade plastics, and sterilization equipment. Hospitals and ambulatory surgical centers in North America and Europe are most affected due to dependence on imported gynecological devices, while Asia-Pacific faces cost pressures on manufacturing exports. These tariffs are raising device procurement costs and influencing purchasing decisions. However, they are also promoting domestic manufacturing, local assembly of surgical tools, and development of cost-optimized uterine manipulation devices.

The uterine manipulators market research report is one of a series of new reports that provides uterine manipulators market statistics, including uterine manipulators industry global market size, regional shares, competitors with a uterine manipulators market share, detailed uterine manipulators market segments, market trends and opportunities, and any further data you may need to thrive in the uterine manipulators industry. This uterine manipulators market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Uterine manipulators are specialized medical instruments used in gynecological surgeries to position, manipulate, and stabilize the uterus, giving surgeons improved access and visibility to the surgical area. These devices are inserted through the cervix or abdominal wall and are designed to adjust the uterus’s orientation and position, facilitating precise surgical procedures.

The main types of uterine manipulators include uterine injectors, Mangeshikar, Clermont Ferrand, Vectec, and others. A uterine injector is a device used to deliver fluids or medications directly into the uterus during gynecological procedures to support diagnosis or treatment. These devices are applied in laparoscopic surgeries, hysteroscopic surgeries, fertility treatments, and other procedures, and are utilized by end users such as specialty clinics, hospitals, and ambulatory surgical centers.

The uterine manipulators market consists of sales of inflatable uterine manipulators, mechanical uterine manipulators, and electro-mechanical uterine manipulators. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.